Filters








4,367 Hits in 10.7 sec

Establishment and Validation of a Predictive Nomogram for Postoperative Survival of Stage I Non-Small Cell Lung Cancer

Zhi-Hui Wang, Lili Deng
2022 International Journal of General Medicine  
Surgical procedure is the preferred option for people with early-stage non-small cell lung cancer (NSCLC), while nearly 30% of patients experienced metastatic or recurrent tumor after operation.  ...  Conclusion: A nomogram was successfully created and verified to achieve the goal that made a rounded accurate prediction on the survival of postoperative I NSCLC patients in terms of the SEER database.  ...  After deleting ineligible objects, we selected a total of more than 10,000 stage I non-small cell lung cancer data with complete variables. Finally, these data were taken as the research object.  ... 
doi:10.2147/ijgm.s361179 fatcat:b67d4yqce5drzfwdkklf2wtttu

Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I–III non-small cell lung cancer (NSCLC) patients with baseline tissue EGFR mutations

Kai Guo, Changjian Shao, Lu Han, Honggang Liu, Zhiqiang Ma, Yang Yang, Yingtong Feng, Minghong Pan, Mariacarmela Santarpia, Maria Carmo-Fonseca, Catarina Silveira, Kye Young Lee (+3 others)
2021 Translational Lung Cancer Research  
Plasma circulating tumor DNA (ctDNA) may be a surrogate, minimally invasive approach to tissue-based epidermal growth factor receptor (EGFR) mutation detection in non-small cell lung cancer (NSCLC) patients  ...  However, the predictive ability of preoperative ctDNA EGFR mutation test on long-term postoperative survival and tumor metastasis development has not been extensively investigated.  ...  Acknowledgments The authors appreciate the academic support from AME Lung Cancer Collaborative Group.  ... 
doi:10.21037/tlcr-21-530 pmid:34430359 pmcid:PMC8350110 fatcat:ibzhub7bffe45j7gar5erhek24

Effectiveness of Perioperative Cardiopulmonary Rehabilitation in Patients With Lung Cancer Undergoing Video-Assisted Thoracic Surgery

Wei-Hao Chao, Sheng-Hui Tuan, En-Kuei Tang, Yi-Ju Tsai, Jing-Hui Chung, Guan-Bo Chen, Ko-Long Lin
2022 Frontiers in Medicine  
ObjectivesPatients with lung cancer pose a high risk of morbidity and mortality after lung resection. Those who receive perioperative cardiopulmonary rehabilitation (PRCR) have better prognosis.  ...  PRCR should be encouraged in patients undergoing VATS for lung cancer.  ...  Lung cancer is categorized into small cell lung cancer and non-small cell lung cancer (NSCLC).  ... 
doi:10.3389/fmed.2022.900165 pmid:35783624 pmcid:PMC9240316 fatcat:5wyyuullpbhkbganbbhmdjqyfe

Pulmonary Resection for Lung Cancer in Patients with Liver Cirrhosis [chapter]

Takashi Iwata
2012 Topics in Thoracic Surgery  
cancer in cirrhotic patients, introducing my recent three cases with a review of the literature.  ...  Topics in Thoracic Surgery 18 In this chapter, I describe about pathophysiology of liver cirrhosis, its effect upon pulmonary function, and safety, risk and feasibility of pulmonary resection for lung  ...  Survival curves after pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma.  ... 
doi:10.5772/27860 fatcat:7bgxuwdzinaw5pf4cbwfxwkxnu

Venous thromboembolism in non-small cell lung cancer patients who underwent surgery after induction therapy

Yasunori Kaminuma, Masayuki Tanahashi, Eriko Suzuki, Naoko Yoshii, Hiroshi Niwa
2020 General Thoracic and Cardiovascular Surgery  
We retrospectively evaluated 89 patients with non-small cell lung cancer who underwent surgery after induction therapy at our department between April 2009 and March 2018.  ...  The incidence of VTE, clinical features, and long-term prognosis were retrospectively examined.  ...  Conclusion This study is the first report investigating the incidence and long-term prognosis of VTE in lung cancer patients who underwent surgery after induction therapy.  ... 
doi:10.1007/s11748-020-01351-0 pmid:32274676 fatcat:aqoscpeg4bchnafricx57dwp6a

Preoperative Master's double two-step test may predict survival after lobectomy in patients with lung cancer

Satoshi Shiono, Makoto Endo, Kenta Nakahashi, Marina Nakatsuka
2022 Journal of Cardiothoracic Surgery  
The purpose of this study was to clarify the relationship between the results of the MDT and prognosis after lung cancer surgery.  ...  Conclusions Although incomplete MDT was not associated with postoperative complications, 90-day mortality or cancer-specific survival, MDT results may be significantly associated with non-cancer-specific  ...  Database We used a database of patients undergoing surgery for non-small cell lung cancer (NSCLC), constructed from the following data: (1) patient demographics (age, gender, smoking status, body height  ... 
doi:10.1186/s13019-022-01850-6 pmid:35505360 pmcid:PMC9066765 fatcat:6h3drlcngbcotaia3526cu6i7q

An individualised radiomics composite model predicting prognosis of stage 1 solid lung adenocarcinoma

H. Chen, M. Liang, X. Li, T. Wu, L. Zhang, X. Liu
2020 Clinical Radiology  
The prognosis of stage I solid lung adenocarcinoma predicted by an individualised radiomics composite model was more accurate than that of the simple radiomics model.  ...  To develop and evaluate a radiomics composite model for predicting disease-free survival (DFS) in stage I solid lung adenocarcinoma, and compare it to a simple radiomics model.  ...  Long-term DFS was confirmed 61 months postoperatively.  ... 
doi:10.1016/j.crad.2020.03.019 pmid:32307110 fatcat:mjtokhdzjre4pecagvcshsrah4

Relationship between red cell distribution width and prognosis in patients with breast cancer after operation: a retrospective cohort study

Deshun Yao, Zhiwu Wang, Haifeng Cai, Ying Li, Baosheng Li
2019 Bioscience Reports  
width (RDW) and long-term prognosis in patients with breast cancer.  ...  RDW could be a potential predictive factor in differential diagnosis of poor prognosis from all patients.  ...  Warwick et al. investigate the association of RDW in patients undergoing lung resections for non-small-cell lung cancer with respect to in-hospital morbidity, mortality, and long-term survival.  ... 
doi:10.1042/bsr20190740 pmid:31262969 pmcid:PMC6629944 fatcat:d7tr4kps3bc2zbdbjhoiculoui

Prognostic factors in NSCLC. Recent experiences

Nico van Zandwijk, Wolter J. Mooi, Sjoerd Rodenhuis
1995 Lung Cancer  
in non-small cell lung cancer (Kubuschok et al. 1999) .  ...  Based on histology, lung cancer is divided into small cell cancer, and non-small cell cancers (adenocarcinoma, epidermoid carcinoma and large cell anaplastic carcinoma).  ...  He adapted contemporary surgical techniques into the routine care of lung cancer patients, and without his personal help this study would have been impossible.  ... 
doi:10.1016/0169-5002(95)00418-z pmid:7551931 fatcat:ui37xwu7svbljcunix5fj6iphm

Risk factors and survival analysis of arrhythmia following lung cancer surgery: a retrospective study

Jialin Gong, Xiaofei Wang, Zuo Liu, Shuang Yao, Zengtuan Xiao, Mengzhe Zhang, Zhenfa Zhang
2021 Journal of Thoracic Disease  
Surgical treatment of lung cancer is one of the important treatments for early-stage non-small cell lung cancer (NSCLC).  ...  We therefore provides guidance for PA in improving the prognosis of lung cancer patients.  ...  ; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; ADC, adenocarcinoma; SCC, squamous cell carcinoma; ASC, adenosquamous carcinoma; SCLC, small cell lung cancer; LCLC, large cell lung cancer.  ... 
doi:10.21037/jtd-20-2740 pmid:33717558 pmcid:PMC7947489 fatcat:4h5ltxseg5dmxiulbgehlumfoe

Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact

Natasha Honoré, Rachel Galot, Cédric van Marcke, Nisha Limaye, Jean-Pascal Machiels
2021 Cancers  
have on the management of cancer patients.  ...  One reason why some patients experience recurrent disease after a curative-intent treatment might be the persistence of residual tumor cells, called minimal residual disease (MRD).  ...  The importance of MRD detection was first highlighted in hematological cancers and allowed clinicians to evaluate the success of therapy and to predict short-and long-term relapse [2] .  ... 
doi:10.3390/cancers13215364 pmid:34771526 pmcid:PMC8582541 fatcat:w5tp72jslngd7bekgahcmmcx7u

Guidelines on the radical management of patients with lung cancer

E. Lim, D. Baldwin, M. Beckles, J. Duffy, J. Entwisle, C. Faivre-Finn, K. Kerr, A. Macfie, J. McGuigan, S. Padley, S. Popat, N. Screaton (+4 others)
2010 Thorax  
cancer who can potentially be managed by radical treatment. < Appendix 2 is published online only.  ...  by the British Thoracic Society and the Society for Cardiothoracic Surgery in Great Britain and Ireland was undertaken to update the 2001 guidelines for the selection and assessment of patients with lung  ...  TNM 7th edition T1e3N1e2M0 non-small cell lung cancer.  ... 
doi:10.1136/thx.2010.145938 pmid:20940263 fatcat:dyvraprucvh2pnnnxatjtn2pvu

23rd Annual Meeting of the Austrian Society of Surgical Oncology (ACO-ASSO) & 11th International Thoracic Surgery Congress, St. Wolfgang, October 5–7, 2006

2006 European surgery  
Bronchopulmonary carcinoma does not have an encouraging prognosis. Lung cancer is the number one killer all over Europe. General thoracic surgery has a glorious past.  ...  In order to be able to decide whether a patient with lung cancer is a candidate for pulmonary resection the extent of the disease and the cardiopulmonary reserve have to be determined.  ...  In lung cancer, research on patient survival has focused mainly on short-term survival as overall prognosis is poor.  ... 
doi:10.1007/s10353-006-0280-6 fatcat:ge2rjoo76fhp3dnssmlnub6h7u

An unusual outcome of papillary renal cell carcinoma with lung metastases: a case report and review of literature

Emmanuel Owusu Ofori, Baba Alhaji Bin Alhassan, Edwina Ayaaba Ayabilah, Patrick Opoku Manu Maison, Alvin Asante-Asamani, Henry Atawura, Ganiyu Adebisi Rahman, Patrick Kafui Akakpo, Emmanuel Gustav Imbeah, Prince Wilson Ofori
2021 African Journal of Urology  
Background Renal cell carcinoma (RCC) is a heterogeneous group of malignant epithelial tumors of the kidney. It accounts for more than 90% of all kidney cancers.  ...  Case presentation The present study reports a papillary renal cell carcinoma with multiple lung metastases in a 31-year-old woman who presented with progressive right flank mass and pain with no chest  ...  Anomalies of MET pathway have been described in several other tumors including hepatocellular carcinomas (HCC), non-small cell lung cancer (NSCLC), breast cancer, ovarian cancer, colorectal cancer (CRC  ... 
doi:10.1186/s12301-020-00103-z fatcat:sgi6eco52bfphfm6fkkotiaoda

Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives

Yan Peng, Wuxuan Mei, Kaidong Ma, Changchun Zeng
2021 Frontiers in Oncology  
Moreover, this review highlights current advancements in utilizing ctDNA to monitor the MRD of solid tumors such as lung cancer, breast cancer, and colon cancer.  ...  Recently, ctDNA has emerged as a promising non-invasive biomarker in clinical oncology.  ...  In a single-center analysis of 323 non-small cell lung cancer patients, 229 had concurrent plasma and tissue NGS or were unable to complete tissue testing.  ... 
doi:10.3389/fonc.2021.763790 pmid:34868984 pmcid:PMC8637327 fatcat:je2d5mdgm5atfpngdclmhpf4aq
« Previous Showing results 1 — 15 out of 4,367 results